(Q81189851)
Statements
Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme (English)
Shuichi Izumoto
Akihiro Tsuboi
Yoshihiro Oka
Tsuyoshi Suzuki
Tetsuo Hashiba
Naoki Kagawa
Naoya Hashimoto
Motohiko Maruno
Olga A Elisseeva
Toshiaki Shirakata
Manabu Kawakami
Yusuke Oji
Sumiyuki Nishida
Satoshi Ohno
Ichiro Kawase
Jun Hatazawa
Shin-Ichi Nakatsuka
Katsuyuki Aozasa
Satoshi Morita
Junichi Sakamoto
Haruo Sugiyama
Toshiki Yoshimine